RecruitingPhase 2NCT01656603
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
Sponsor
New York Blood Center
Enrollment
9,999 participants
Start Date
Feb 1, 2012
Study Type
INTERVENTIONAL
Conditions
Summary
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Eligibility
Inclusion Criteria3
- Diagnosis: Patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.
- Patients: Patients of any age and either gender
- Cord blood product manufactured by the NCBP (at least one, if the graft contains more than one units)
Exclusion Criteria4
- Patients who are receiving licensed cord blood products (only)
- Patients who are receiving unlicensed cord blood products from other banks (only)
- Patients who are transplanted at non-US transplant centers
- Patients who are receiving cord blood products that will be "manipulated" post-thaw (e.g., ex vivo expansion, incubation in vitro, etc.)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALunlicensed CBU
infusion of unlicensed cord blood units
Locations(71)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01656603